Medigus
OMER, L3 · CIK 0001618500 · Medtech · Public
MUSE endoscopic stapling system for minimally invasive gastroesophageal reflux disease treatment
medigus.com →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- $8.6M
- 3 Form D · Nov 2017
- 106 months since last filing
- Contracts
- $623K
- 2 awards · NASA
- #367 of 4531 in medtech
- Patents
- 9
- 4 granted · 5 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓2012201320142015201620172018
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal contract | National Aeronautics and Space Administration · Cmos Camera Integrated With Illumination Unit (18 Each) Rainbow Video Processor (1 Each) Interface Control Document (1 Each) Shipping | $122,800 | |
| Private capital raised | Form D · SEC | $5,627,538 | |
| Federal contract | National Aeronautics and Space Administration · [igf::ot::igf] A Fully Integrated Camera Head Unit. This Camera Head Unit Would Contain The Aforementioned Miniaturized Camera, Integrated Led Lighting, Led Diffuser And A Mechanical Housing To Contain All Of The Camera Head Components. | $500,000 | |
| Private capital raised | Form D · SEC | $3,006,296 | |
| Private capital raised | Form D · SEC | $4,050 |
Federal contract · USAspendingForm D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 364 | X-BIOMEDICAL INC | $646K | $425K |
| 365 | Starr Life Sciences Corp. | $642K | $4.1M |
| 366 | Beacon Biosignals | $641K | $133M |
| 367 | Medigus | $623K | $8.6M |
| 368 | Sentien Biotechnologies, Inc. | $610K | $1.0M |
| 369 | PGXL TECHNOLOGIES LLC | $606K | — |
| 370 | Ribomed Biotechnologies, Inc. | $603K | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Avraham Ben-TzviExecutive Officer
- Doron BirgerDirector
- Erez ChimovitzDirector
- Nissim DarvishDirector
- Thomas DempseyExecutive Officer
- Ori HershkovitzDirector
- Ori HershkowitzDirector
- Eitan MachoverDirector
- Anat NaschitzDirector
- Yari RabinowitzDirector
- Milena RidlExecutive Officer
- Chistopher RowlandDirector · Executive Officer
- Christopher RowlandDirector · Executive Officer
- Aviel Roy-ShapiraExecutive Officer
- Avraham Sarusi, GabbyDirector
- Yaron SilbermanExecutive Officer
- Minelu SonnenscheinExecutive Officer
- Jeremy StarkweatherExecutive Officer
- Efrat VenkertDirector
- Oded YatzkanExecutive Officer
Patents
- Endoscope Devices Comprising A Moveable Cameraapplication
- Camera Headgranted
- Integrated Endoscope Irrigationgranted
- Camera Headgranted
- Endoscope-like Devices Comprising Sensors That Provide Positional Informationapplication
- Small Diameter Video Camera Heads And Visualization Probes And Medical Devices Containing Themgranted
- Integrated Endoscope Irrigationapplication
- Stapler For Endoscopesapplication
- Small Diameter Video Camera Heads And Visualization Probes And Medical Devices Containing Themapplication
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.